Showing results (661-670 of 706) with videos related to

Sort By:
Pageof 71
Urologic Oncology|March 17, 2020
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorMatteo Ferro, Martha Orsolya Katalin, Carlo Buonerba, et al.
European Urology Oncology|June 4, 2019
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder CancerFrancesco Cantiello, Giorgio I Russo, Mihai Dorin Vartolomei, et al.
Urologic Oncology|June 8, 2022
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancerMatteo Ferro, Biagio Barone, Felice Crocetto, et al.
BJU International|July 4, 2024
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleedingLuca Antonelli, Pedro David Wendel-Garcia, Manja Deforth, et al.
World Journal of Urology|July 12, 2018
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancerMatteo Ferro, Mihai Dorin Vartolomei, Giorgio Ivan Russo, et al.
Journal of Cancer|December 7, 2018
Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder CancerMatteo Ferro, Giuseppe Di Lorenzo, Carlo Buonerba, et al.
The Journal of Experimental Medicine|December 5, 2025
Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitisAdrian Gervais, Astrid Marchal, Soraya Boucherit, et al.
The Journal of Experimental Medicine|September 24, 2024
Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patientsAdrian Gervais, Astrid Marchal, Andrea Fortova, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin ImmunotherapyMatteo Ferro, Octavian Sabin Tătaru, Gennaro Musi, et al.
World Journal of Urology|April 18, 2019
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorM Ferro, G Di Lorenzo, M D Vartolomei, et al.
Pageof 71